Hemorrhage of brain metastasis is a poor prognostic factor in hepatocellular carcinoma patients

Yan Lin; Shi-Ting Huang; Yan-Ming Jiang; Xin-Bin Pan

doi:10.18632/oncotarget.21449

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Clinical Research Papers:

Hemorrhage of brain metastasis is a poor prognostic factor in hepatocellular carcinoma patients

Yan Lin, Shi-Ting Huang, Yan-Ming Jiang and Xin-Bin Pan _

PDF | HTML | How to cite

Oncotarget. 2017; 8:93245-93250. https://doi.org/10.18632/oncotarget.21449

Metrics: PDF 1276 views | HTML 2068 views | ?

Abstract

Yan Lin2, Shi-Ting Huang1, Yan-Ming Jiang1 and Xin-Bin Pan1

1 Department of Radiation Oncology, Cancer Hospital of Guangxi Medical University, Nanning, Guangxi, P.R. China

2 Department of Gastroenterology, The Third People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, P.R. China

Correspondence to:

Xin-Bin Pan, email:

Keywords: hepatocellular carcinoma, brain metastasis, hemorrhage

Received: June 09, 2017 Accepted: August 17, 2017 Published: October 03, 2017

Abstract

It is unclear whether hemorrhage of brain metastasis is a poor prognostic factor in patients with hepatocellular carcinoma. We conducted a retrospective cohort study to compare overall survival between hemorrhage and no-hemorrhage groups of hepatocellular carcinoma patients with brain metastasis. Hepatocellular carcinoma patients with brain metastasis treated between June 2000 and June 2016 at the Cancer Hospital of Guangxi Medical University were retrospectively reviewed. Clinical characteristics and overall survival were compared between patients with (n = 11) and without (n = 25) hemorrhage of brain metastasis. Univariate and multivariate survival analyses showed hemorrhage to be a poor prognostic factor (hazard ratio = 5.812, 95% confidence interval: 1.399-24.142, p = 0.015). Patients with hemorrhage had a shorter median survival than those without hemorrhage (4 weeks vs 8 weeks, p = 0.001). These results suggest hemorrhage of brain metastasis is a poor prognostic factor in patients with hepatocellular carcinoma patients.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 21449

Publication Alerts

Oncoscience

Post-Publication Promotion

Clinical Research Papers:

Hemorrhage of brain metastasis is a poor prognostic factor in hepatocellular carcinoma patients

Abstract